GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rossmax International 4121.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

12.10

+1.26%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 3.80bn

FY2016FY2025

Net income

−TWD 29.9m

FY2016FY2025

Free cash flow

TWD 236.7m

FY2016FY2025

Shareholders' equity

TWD 1.41bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 3.80bnTWD 3.85bnTWD 3.81bnTWD 4.34bnTWD 3.95bnTWD 3.68bnTWD 3.09bnTWD 3.10bnTWD 3.15bnTWD 3.13bn
Gross profitTWD 1.31bnTWD 1.33bnTWD 1.27bnTWD 1.51bnTWD 1.30bnTWD 1.23bnTWD 983.1mTWD 954.8mTWD 963.5mTWD 891.8m
Research and developmentTWD 53.3mTWD 51.6mTWD 50.9mTWD 53.8mTWD 55.8mTWD 58.9mTWD 64.4mTWD 43.1mTWD 40.6mTWD 45.7m
Operating income−TWD 72.4m−TWD 76.7mTWD 39.1mTWD 297.8mTWD 181.5mTWD 200.9mTWD 59.2mTWD 30.7mTWD 47.3m−TWD 122.4m
Net income−TWD 29.9m−TWD 29.3m−TWD 6.7mTWD 170.3mTWD 111.4mTWD 135.5mTWD 25.7mTWD 16.6mTWD 27.7mTWD 20.1m
Diluted earnings per share-0.37-0.37-0.082.001.321.710.320.210.340.27

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 4.21bnTWD 4.23bnTWD 4.09bnTWD 3.99bnTWD 3.76bnTWD 3.36bnTWD 3.06bnTWD 2.30bnTWD 2.41bnTWD 2.20bn
Cash and short-term investments——TWD 691.3mTWD 816.5mTWD 916.7mTWD 1.06bnTWD 28.5m——TWD 698.3m
Total liabilitiesTWD 2.22bnTWD 2.14bnTWD 2.24bnTWD 2.05bnTWD 1.98bnTWD 1.70bnTWD 1.73bnTWD 958.0mTWD 1.06bnTWD 1.09bn
DebtTWD 186.8mTWD 135.9mTWD 1.39bnTWD 1.12bnTWD 1.08bnTWD 936.7mTWD 386.8mTWD 245.5mTWD 306.6mTWD 292.4m
Shareholders' equityTWD 1.41bnTWD 1.48bnTWD 1.44bnTWD 1.55bnTWD 1.45bnTWD 1.34bnTWD 1.12bnTWD 1.12bnTWD 1.14bnTWD 1.11bn
Shares outstanding80m80m85m85m84m79m80m80m80m74m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 284.2mTWD 314.1mTWD 302.4mTWD 434.2mTWD 575.4mTWD 459.3mTWD 81.9mTWD 23.6m−TWD 97.6m−TWD 28.7m
Capital spending−TWD 47.5m−TWD 75.6m−TWD 107.3m−TWD 134.7m−TWD 349.8m−TWD 81.6m−TWD 41.5m−TWD 46.5m−TWD 38.6m−TWD 118.2m
Free cash flowTWD 236.7mTWD 238.5mTWD 195.0mTWD 299.5mTWD 225.6mTWD 377.7mTWD 40.5m−TWD 22.9m−TWD 136.2m−TWD 146.9m
Dividends paid—−TWD 48.8m−TWD 101.9m−TWD 92.8m−TWD 95.2m−TWD 14.7m−TWD 7.3m−TWD 21.9m−TWD 21.9m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 946.7mTWD 938.3mTWD 950.9mTWD 941.1mTWD 981.8mTWD 925.8mTWD 969.6mTWD 973.8m
Gross profitTWD 319.7mTWD 317.9mTWD 319.4mTWD 325.2mTWD 340.9mTWD 320.8mTWD 320.4mTWD 332.2m
Operating income−TWD 26.0m−TWD 22.2m−TWD 29.4m−TWD 23.9mTWD 905,000−TWD 19.9m−TWD 35.8m−TWD 28.5m
Net income−TWD 16.5m−TWD 9.2m−TWD 6.6m−TWD 7.9m−TWD 5.1m−TWD 10.3m−TWD 13.3m−TWD 12.3m
Diluted earnings per share-0.20-0.12-0.08-0.09-0.06-0.13-0.17-0.15
Cash from operationsTWD 102.0mTWD 40.0mTWD 87.0m—TWD 103.0mTWD 45.0mTWD 165.0mTWD 79.0m
Capital spending−TWD 8.0m−TWD 12.0m−TWD 18.0m—−TWD 10.0m−TWD 7.0m−TWD 20.0m−TWD 12.0m
Free cash flowTWD 94.0mTWD 28.0mTWD 69.0m—TWD 93.0mTWD 38.0mTWD 145.0mTWD 67.0m
Total assetsTWD 4.00bnTWD 4.08bnTWD 4.21bn—TWD 4.14bnTWD 4.20bnTWD 4.23bnTWD 4.29bn
DebtTWD 232.2mTWD 234.5mTWD 186.8m—TWD 131.3mTWD 134.0mTWD 135.9mTWD 138.5m
Shareholders' equityTWD 1.38bnTWD 1.39bnTWD 1.41bn—TWD 1.43bnTWD 1.48bnTWD 1.48bnTWD 1.50bn

Financial ratios

Data as of 3 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin34.4%34.7%33.4%34.7%32.8%33.5%
Operating margin-0.9%-0.6%1.0%6.9%4.6%5.5%
Net margin-0.8%-0.8%-0.2%3.9%2.8%3.7%
Return on equity-2.1%-2.0%-0.5%11.0%7.7%10.1%
Return on assets-0.7%-0.7%-0.2%4.3%3.0%4.0%
Free cash flow yield—39.1%38.8%54.0%88.5%55.0%
Revenue growth-1.3%1.1%-12.3%10.1%7.3%18.9%
Earnings growth1.9%340.3%-103.9%52.9%-17.8%426.5%
Current ratio1.92x2.04x1.73x1.87x1.87x2.20x
Debt to equity0.13x0.09x0.38x0.27x0.35x0.33x
Equity ratio33.5%35.0%35.3%38.9%38.5%40.0%
Interest coverage-1.24x-0.77x1.54x12.96x9.15x9.25x
R&D as a share of sales1.4%1.3%1.3%1.2%1.4%1.6%
Buybacks as a share of market value—5.7%-0.2%-0.7%-6.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.4%0.6%1.1%
Operating income——-5.5%
Net income——0.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin34.5%34.3%33.9%32.3%
Operating margin-1.9%1.2%2.4%1.2%
Net margin-0.8%0.7%1.5%1.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-41.9-48.2-319.312.216.012.337.150.437.344.1
Price to sales0.30.40.60.50.50.50.30.30.30.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 12 Jun 2024.

FY2024FY2023FY2022
Paid in the year0.501.201.092
  • 1.04-for-1 split · 10 Aug 2011
  • 1050-for-1000 split · 15 Jun 2010
  • 105-for-100 split · 11 Aug 2009
  • 102.518-for-100 split · 20 Aug 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.